Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children

American Journal of Hematology

Volumn 87, Issue 2, 2012, Pages 145-149

  Noubouossie, Denis F ^a   Lê, Phu Quoc ^b   Corazza, Francis ^c   Debaugnies, France ^a   Rozen, Laurence ^a   Ferster, Alina ^b   Demulder, Anne ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^c Laboratory of Immunology Centre   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; PROTEIN C; PROTEIN S; THROMBIN; THROMBOMODULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CHILD; CONTROLLED STUDY; ENDOGENOUS THROMBIN POTENTIAL; ENZYME ACTIVITY; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SICKLE CELL ANEMIA; STEADY STATE; THROMBIN GENERATION; VASOOCCLUSIVE CRISIS;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; PHOSPHOLIPIDS; PROTEIN C; PROTEIN S; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN;

EID: 84855943819     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22206     Document Type: Article

References (29)

1. Franceschi LD, Cappellini MD, Olivieri O. Thrombosis and sickle cell disease. Semin Thromb Hemost 2011; 37: 226-236.
2. Austin H, Key NS, Benson JM, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007; 110: 908-912.
3. Adedeji MO, Cespedes J, Allen K, et al. Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Arch Pathol Lab Med 2001; 125: 1436-1441.
4. Mekontso Dessap A, Deux J-F, et al. Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 2011; 11. Available from:
5. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998; 91: 288-294.
6. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: New approaches to an old problem. Hematology 2007: 91-96.
7. Nsiri B, Gritli N, Bayoudh F, et al. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease. Hematol Cell Ther 1996; 38: 279-284.
8. Westerman MP, Green D, Gilman-Sachs A, et al. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med 1999; 134: 352-362.
9. Hagger D, Wolff S, Owen J, et al. Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls. Blood Coagul Fibrinolysis 1995; 6: 93-99.
10. van Beers EJ, Schaap MCL, Berckmans RJ, et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009; 94: 1513-1519.
11. Westerman M, Pizzey A, Hirschman J, et al. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol 2008; 142: 126-135.
12. van Tits LJ, van Heerde WL, Landburg PP, et al. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis. Biochem Biophys Res Commun 2009; 390: 161-164.
13. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
14. Hemker HC, Giesen P, AlDieri R, et al. The calibrated automated thrombogram (CAT): A universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-253.
15. Lutsey PL, Cushman M, Steffen LM, et al. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: The MESA study. J Thromb Haemost 2006; 4: 2629-2635.
16. Chaari M, Stankovic K, Galea V, et al. Steady state sickle cell anemia is associated with increased formation of erythrocyte-derived microparticles and acceleration of thrombin generation. ASH Annu Meeting Abstr 2009; 114: 4001.
17. Betal SG, Kato GJ, Lawrence MP, et al. Thrombin generation in sickle cell disease: Insights from computerized automated thrombography. ASH Annu Meeting Abstr 2009; 114: 2587.
18. Dargaud Y, Luddington R, Gray E, et al. Effect of standardization and normalization on imprecision of calibrated automated thrombography: An international multicentre study. Br J Haematol 2007; 139: 303-309.
19. Ataga KI. Hypercoagulability and thrombotic complications in hemolytic anemias. Haematologica 2009; 94: 1481-1484.
20. Dielis AWJH, Castoldi E, Spronk HMH, et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008; 6: 125-131.
21. Mohan JS, Lip GY, Wright J, et al. Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation. Blood Coagul Fibrinolysis 2005; 16: 209-214.
22. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102: 2678-2683.
23. Gerotziafas GT, Depasse F, Busson J, et al. Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay. Thromb J 2005; 3: 16.
24. Wright JG, Cooper P, Malia RG, et al. Activated protein C resistance in homozygous sickle cell disease. Br J Haematol 1997; 96: 854-856.
25. Steen RG, Emudianughe T, Hankins GM, et al. Brain imaging findings in pediatric patients with sickle cell disease. Radiology 2003; 228: 216-225.
26. Telfer P, Coen P, Chakravorty S, et al. Clinical outcomes in children with sickle cell disease living in England: A neonatal cohort in East London. Haematologica 2007; 92: 905-912.
27. Peters M, Plaat BE, ten Cate H, et al. Enhanced thrombin generation in children with sickle cell disease. Thromb Haemost 1994; 71: 169-172.
28. Dargaud Y, Hierso S, Rugeri L, et al. Endogenous thrombin potential, prothrombin fragment 1+2 and D-dimers during pregnancy. Thromb Haemost 2010; 103: 469-471.
29. van Veen JJ, Gatt A, Cooper PC, et al. Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagul Fibrinolysis 2008; 19: 183-189.